evaluation 2026-04-18 13 min read the underwriting desk

Best peptide payment processors in 2026

3-minute scan
  • Stripe, Square, PayPal, Shopify Payments all decline peptides. Do not apply.
  • Domestic options: Durango, EasyPayDirect, Corepay, PayKings through Authorize.net or NMI.
  • Multi-brand peptide portfolios benefit from parent account + orchestration instead of N single-MID applications.
On this page

    Peptide operators have two payment problems: getting approved, and staying approved. This roundup ranks the processors that solve both for 2026. We run a peptide-friendly orchestration stack ourselves, so we'll tell you straight where we fit and where another processor is the better call.

    Who definitely won't approve you

    Stripe, Square, PayPal, Braintree, Shopify Payments, Venmo for Business, Cash App for Business — all decline peptides per their acceptable use policies. Operators who sneak through get closed within 3-6 months of processing. Don't waste application attempts. See Stripe, Square, PayPal, and Shopify Payments comparisons.

    How we ranked

    We scored each option on: peptide approval probability, SKU review strictness, effective rate, reserve structure, chargeback tolerance, onboarding speed, and multi-brand support. For single-brand operators, the first four weigh most. For 3+ brand operators, multi-brand support becomes decisive.

    The roundup

    1. EasyPayDirect (EPD) — Winner, single-brand peptide

    EPD has the widest peptide SKU tolerance among specialist ISOs we've seen. They take research-labeled peptides, not-for-human-consumption labels, and most standard peptide product lines. Pairing with Authorize.net gateway is standard.

    Rates: 3.5-4.5% effective, depending on volume and chargeback history.

    Reserves: 10-15% rolling 180 days for first-year accounts.

    Catch: 2-3 year contracts, ETF $250-$500. Negotiate before signing.

    2. Durango Merchant Services — Runner-up, broad peptide coverage

    Durango's peptide book is long-tenured. They'll approve most compliant peptide operators and have the relationship depth to renegotiate rates at 12 months of clean processing.

    Rates: 3.5-4.5% effective.

    Reserves: 10-15% rolling 180 days typical.

    See Durango comparison.

    3. Corepay — Best for CBD + peptide hybrid operators

    Corepay's sweet spot is operators running CBD + peptide together. They underwrite each vertical on its own merit and you end up with one ISO relationship covering both books.

    Rates: 3.6-4.3% effective.

    Reserves: 10-15% rolling 180 days.

    4. PayKings — Best for peptide subscription models

    PayKings has tooling and relationships that work well for subscription peptide offers — auto-renewal, first-month discount funnels, subscription chargeback management. Tighter SKU review than Durango.

    Rates: 3.9-4.5% effective.

    Reserves: 10-15% rolling 180 days.

    5. multiflow — Best for 3+ brand peptide portfolios

    We're the answer when you're running multiple peptide brands, or peptide + nutra combinations, and the overhead of N separate ISO relationships is the actual pain point. Parent account with brand-level descriptors, consolidated chargeback queue, and orchestration failover across acquirers.

    Rates: 5.5-7.5% per transaction + setup fee. Higher than a single-brand EPD quote; lower total cost at 5+ brands once reconciliation and multi-MID overhead is factored.

    Catch: We don't onboard single-brand peptide operators. Use EPD/Durango for that.

    6. Soar Payments — Best for new peptide operators

    Soar is more flexible on operators without 6+ months of processing history. Good first-processor option if you're just launching a peptide brand.

    Rates: 4.0-4.5% effective.

    See Soar comparison.

    7. High Risk Pay — Best for post-MATCH recovery

    High Risk Pay takes operators coming off MATCH more readily than other specialist ISOs. Higher rate and heavier reserve, but it's often the "get back processing" answer while cleaning history.

    Rates: 4.5-5.5% effective for post-MATCH accounts.

    Reserves: 15-20% rolling 180 days.

    See High Risk Pay comparison.

    8. Offshore acquirers (EU/Canada) — Best for $500k+/mo peptide volume

    Emerchantpay (EU), Global Payments Canada, and Paynetics underwrite US peptide merchants at volume. FX costs and slower chargeback resolution are real trade-offs.

    See Global Payments comparison.

    Sortable comparison table

    ProcessorBest forEffective rateReserveOnboardingSKU strictness
    EasyPayDirectSingle-brand peptide3.5-4.5%10-15% / 180d10-15 daysPermissive
    DurangoBroad peptide3.5-4.5%10-15% / 180d10-15 daysPermissive
    CorepayCBD+peptide hybrid3.6-4.3%10-15% / 180d10-14 daysModerate
    PayKingsPeptide subs3.9-4.5%10-15% / 180d7-10 daysStrict
    multiflow3+ peptide brands5.5-7.5%5-10% rolling14-30 daysCase-by-case
    SoarNew operators4.0-4.5%10-15% / 180d5-10 daysModerate
    High Risk PayPost-MATCH4.5-5.5%15-20% / 180d10-15 daysCase-by-case
    Offshore$500k+/mo4.0-5.5%15-20% / 180d30-60 daysModerate

    What to evaluate

    For peptide specifically, these matter more than rate: website disclaimer compliance ("for research use only", age gate, consent), SKU list vs. FDA status, chargeback reason code distribution (product-quality reasons drop you faster than fraud), refund policy visibility, and COA availability per SKU. All of these affect your underwriting outcome more than a 20 bps rate difference.

    Multi-brand peptide portfolios

    If you're running multiple peptide brands — different audiences, different price points, different affiliate channels — the stack decision is whether to keep them on N separate MIDs (one per brand) or consolidate under one parent account with brand-level descriptors. We cover the tradeoffs in the peptide operator playbook.

    What NOT to do

    • Don't apply to Stripe pretending to be a supplement company. Review catches this within 24 hours and you get listed as a misrepresentation risk.
    • Don't sign with an ISO promising "no reserves" on peptides. Those close operators in month 3-6 when the acquirer flags the book.
    • Don't sell peptide products with vague labeling. Acquirer review reads your product pages; unclear "for research" framing with consumption language kills applications.
    • Don't cluster chargebacks at launch by running aggressive affiliate funnels before your processor is stable. First 90 days of history set your reserve and rate for the next year.

    What to do next

    Single-brand operator: apply to 2-3 specialist ISOs in parallel. Compare actual contracts. Pilot one brand before consolidating others.

    Multi-brand peptide operator: read the peptide playbook, run the multi-MID math, and submit our 12-question application for an honest fit check.

    On MATCH or recovering from closure: read the MATCH playbook first.

    Found this useful? Share it X LinkedIn Reddit HN Email

    FAQ

    Are peptides federally legal to sell in the US?
    Research-use peptides with proper labeling and compliant marketing operate in a legal gray zone. Sale as consumption products for humans triggers FDA enforcement risk. Your processor cares about both your labels and your marketing, not just your label.
    What rates should I expect as a new peptide operator?
    3.9-4.5% effective rate for year one; rolling to 3.5-4.0% after 12-18 months of clean processing. Reserves 10-15% rolling 180 days.
    Can Shopify store owners process peptide?
    Not via Shopify Payments. You install a third-party gateway (Authorize.net, NMI) alongside Shopify Payments or on a non-Shopify-Payments store. Some Shopify themes make this awkward.
    What SKUs trigger decline most often?
    Growth hormone variants, SARM-adjacent compounds with consumption framing, anything with DEA-scheduled precursor overlap, and anything marketed with dosing instructions for humans.
    Do I need a DSHEA disclaimer on my site?
    You need an "FDA has not evaluated" statement if your labels imply supplement/health claims, plus research-use disclaimers if applicable. Consult a regulatory attorney; processor review will notice missing disclaimers.
    What if my first processor closes me?
    Read our closure playbook. The next processor will know, so prepare the application carefully: explain the closure reason, show chargeback reduction measures, and apply to 1-2 specialist ISOs, not 10.

    Running multiple brands?
    multiflow was built for this.

    The Operator Briefing

    Twice-monthly. No fluff.

    Processor shutdowns, reserve-hold playbooks, reconciliation lessons, and the merchant-account decisions that save operators six-figure years. Delivered to your inbox — never spam.

    No spam. Unsubscribe in one click.

    We use essential cookies · Privacy